BioCentury
ARTICLE | Clinical News

S*BIO, Verastem preclinical data

November 19, 2012 8:00 AM UTC

In a mouse model of breast cancer, 25 mg/kg oral VS-5584 significantly reduced the percent of cancer stem cells in extracted tumors vs. untreated controls. In a mouse model of docetaxel-resistant trip...